The third case of Cabergoline-associated valvulopathy: The value of routine cardiovascular examination for screening

Abstract

A decade after the alarming association of cabergoline-associated valvulopathy (CAV) in Parkinson disease, only two confirmed cases have occurred in patients with prolactinoma. Routine screening for CAV by echocardiography has not proved to be of diagnostic utility, has several limitations, and is notwidely practiced. Wehave previously highlighted the value of annual cardiovascular examination as a screening tool for CAV in patients with prolactinoma.We present a case, now the third confirmed case of CAV, to highlight the value of the cardiovascular examination. A 52-year-old woman with a 25-year history of macroprolactinoma had received multimodal treatment, including surgery, radiosurgery,..